Skip to main content

Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.

Publication ,  Journal Article
Matthay, MA; Anversa, P; Bhattacharya, J; Burnett, BK; Chapman, HA; Hare, JM; Hei, DJ; Hoffman, AM; Kourembanas, S; McKenna, DH; Ortiz, LA ...
Published in: Am J Respir Crit Care Med
August 1, 2013

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health convened the Cell Therapy for Lung Disease Working Group on November 13-14, 2012, to review and formulate recommendations for future research directions. The workshop brought together investigators studying basic mechanisms and the roles of cell therapy in preclinical models of lung injury and pulmonary vascular disease, with clinical trial experts in cell therapy for cardiovascular diseases and experts from the NHLBI Production Assistance for Cell Therapy program. The purpose of the workshop was to discuss the current status of basic investigations in lung cell therapy, to identify some of the scientific gaps in current knowledge regarding the potential roles and mechanisms of cell therapy in the treatment of lung diseases, and to develop recommendations to the NHLBI and the research community on scientific priorities and practical steps that would lead to first-in-human trials of lung cell therapy.

Duke Scholars

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

August 1, 2013

Volume

188

Issue

3

Start / End Page

370 / 375

Location

United States

Related Subject Headings

  • United States
  • Respiratory System
  • National Heart, Lung, and Blood Institute (U.S.)
  • Lung Diseases
  • Humans
  • Cell- and Tissue-Based Therapy
  • Biomedical Research
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Matthay, M. A., Anversa, P., Bhattacharya, J., Burnett, B. K., Chapman, H. A., Hare, J. M., … Blaisdell, C. J. (2013). Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med, 188(3), 370–375. https://doi.org/10.1164/rccm.201303-0522WS
Matthay, Michael A., Piero Anversa, Jahar Bhattacharya, Bruce K. Burnett, Harold A. Chapman, Joshua M. Hare, Derek J. Hei, et al. “Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.Am J Respir Crit Care Med 188, no. 3 (August 1, 2013): 370–75. https://doi.org/10.1164/rccm.201303-0522WS.
Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, et al. Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med. 2013 Aug 1;188(3):370–5.
Matthay, Michael A., et al. “Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.Am J Respir Crit Care Med, vol. 188, no. 3, Aug. 2013, pp. 370–75. Pubmed, doi:10.1164/rccm.201303-0522WS.
Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thébaud B, Trapnell BC, Weiss DJ, Yuan JX-J, Blaisdell CJ. Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med. 2013 Aug 1;188(3):370–375.

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

August 1, 2013

Volume

188

Issue

3

Start / End Page

370 / 375

Location

United States

Related Subject Headings

  • United States
  • Respiratory System
  • National Heart, Lung, and Blood Institute (U.S.)
  • Lung Diseases
  • Humans
  • Cell- and Tissue-Based Therapy
  • Biomedical Research
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 11 Medical and Health Sciences